Thank you very much.
Thank you to the witnesses for appearing.
I'm going to put a question to Dr. Salama and Dr. Dhami.
The data shows that new superbugs, antimicrobial-resistant bugs, are going to transit to $2 trillion in costs to the global economy by 2050. We talked a little about some of the needs and imperatives for funding. One of the things I'm quite concerned about is that most of these bugs don't think about land or air borders in the way that humans do. These things travel. They cannot be managed by any one country on its own. However, we're seeing a tremendous amount of rhetoric and funding cuts coming out of other countries, particularly the United States. We saw a $379-million cut recently to antimicrobial resistance research in the United States.
What is the global impact of getting this wrong? What are the concerns that we should all have, as Canadians and global citizens, with this consistent and rapid erosion of funding across the world for this type of research? We still see the attitudinal approach that humanity heals itself. We're hearing a lot of this stuff about how things take care of themselves.
How would you respond to those two things, and what should we be most concerned about?
I'll start with you, sir, and then go to Dr. Dhami.